Fig. 2From: The limited use of autologous hematopoietic stem cell transplant for fit older patients with multiple myeloma in India: a retrospective analysisSurvival curves revealing significant differences as per the Hematopoietic Stem Cell Transplant Comorbidity Index (HSCT-CI) fitness scores (p 0.0362) (A) & the Revised-Myeloma Comorbidity Index (R-MCI) risk scores (p 0.0253) (B)Back to article page